A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH.

Mohamed OsmanAnoop MistryAda KedingRhian GabeElizabeth CookSarah ForresterRebecca WigginsStefania Di MarcoStefano CollocaLoredana SianiRiccardo CorteseDeborah F SmithToni AebischerPaul M KayeCharles J Lacey

Published in: PLoS neglected tropical diseases (2017)

This clinical trial (LEISH1) was registered at EudraCT (2012-005596-14) and ISRCTN (07766359).

Keyphrases

clinical trial
endothelial cells
induced pluripotent stem cells
study protocol
phase ii
randomized controlled trial
open label